Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT02635204

Public ClinicalTrials.gov record NCT02635204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the efficacy and safety of DFD-06 Cream to Vehicle Cream for topical treatment of moderate to severe plaque psoriasis after 3, 7, and 14 days of treatment.

Study identification

NCT ID
NCT02635204
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Promius Pharma, LLC
Industry
Enrollment
267 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2015 (Type not available)
Primary completion
Jul 2016 (Actual)
Completion
Jul 2016 (Actual)
Last update posted
May 15, 2018

2015 – 2016

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Site 116 Glendale Arizona 85308 —
Site 111 Rogers Arkansas 72758 —
Site 124 Fountain Valley California 92708 —
Site 120 Laguna Hills California 92653 —
Site 122 San Diego California 92108 —
Site 123 San Diego California 92123 —
Site 113 Denver Colorado 80220 —
Site 117 New Haven Connecticut 06511 —
Site 108 Brandon Florida 33511 —
Site 112 Coral Gables Florida 33134 —
Site 106 Jacksonville Florida 32204 —
Site 110 Pinellas Park Florida 33781 —
130 West Palm Beach Florida 33406 —
Site 103 Arlington Heights Illinois 60005 —
Site 115 Overland Park Kansas 66215 —
Site 127 Beverly Massachusetts 01915 —
Site 119 Quincy Massachusetts 02169 —
129 Henderson Nevada 89052 —
Site 114 New York New York 10019 —
Site 104 Rocky Mount North Carolina 27804 —
Site 105 Wilmington North Carolina 28401 —
Site 126 Cincinnati Ohio 45255 —
Site 121 Warwick Rhode Island 02886 —
Site 107 Nashville Tennessee 37215 —
128 Arlington Texas 76014 —
Site 101 Dallas Texas 75234 —
Site 102 Houston Texas 77056 —
Site 109 San Antonio Texas 78229 —
Site 118 Norfolk Virginia 23507 —
Site 125 Richmond Virginia 23294 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02635204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2018 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02635204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →